Explanatory Note
This Amendment No. 3 to the Schedule 13D (this “Amendment No. 3”) filed by the Reporting Persons relates to the continuation of discussions between the Reporting Persons and Quorum Health Corporation, a Delaware corporation (the “Issuer”) since the date of the Schedule 13D filed on April 11, 2019, as amended by Amendment No. 1 filed on February 5, 2020 and Amendment No. 2 filed on April 10, 2020, with respect to the Common Stock of the Issuer (the “Schedule 13D Filing”). This Amendment No. 3 amends and supplements the Schedule 13D Filing. Except as otherwise specified in this Amendment No. 3, all previous Items are unchanged. Unless otherwise indicated herein, capitalized terms used but not defined in this Amendment No. 3 shall have the same meanings as are ascribed to such terms in the Schedule 13D Filing.
Item 4. Purpose of Transaction
Item 4 is hereby amended and supplemented as follows:
As described by the Issuer in its Current Report on Form 8-K dated April 13, 2020 (the “Second Issuer 8-K”), the Issuer, certain of the Consenting Stakeholders, as lenders, including certain affiliates of DKCM, and the other parties thereto, entered into a Superpriority Secured Debtor-in-Possession Credit Agreement, dated April 10, 2020 (the “DIP Credit Agreement”) to provide the Issuer debtor-in-possession financing for working capital and other purposes. In connection with the Chapter 11 Cases, the Bankruptcy Court approved the DIP Credit Agreement on April 9, 2020, on an interim basis. Material terms of the DIP Credit Agreement are described in the Second Issuer 8-K.
The foregoing description of the DIP Credit Agreement does not purport to be complete and is qualified in its entirety by reference to the agreement, filed as Exhibit 99.3 hereto, and is incorporated herein by reference.
Item 6. Agreements
Item 6 is hereby amended and supplemented as follows:
The information set forth in Item 4 above is incorporated herein by reference.
Item 7. Material to Be Filed as Exhibits
Item 7 is hereby amended and supplemented as follows:
| Exhibit 99.3 | Debtor-in-Possession Credit Agreement, dated April 10, 2020, by and among the Issuer and certain of the Consenting Stakeholders, incorporated herein by reference to Exhibit 10.1 to the Second Issuer8-K. |